Psoriatic arthritis: still room for improvement

Affiliations

¹ DANBIO Registry and Copenhagen Center for Arthritis Research, Rigshospitalet, DK-2600 Glostrup, Denmark; University of Copenhagen, Copenhagen, Denmark. Electronic address: merete.hetland@dadlnet.dk.

Comment

Merete Lund Hetland. Lancet. 2020.

. 2020 May 9;395(10235):1463-1465.

doi: 10.1016/S0140-6736(20)30800-X.

¹ DANBIO Registry and Copenhagen Center for Arthritis Research, Rigshospitalet, DK-2600 Glostrup, Denmark; University of Copenhagen, Copenhagen, Denmark. Electronic address: merete.hetland@dadlnet.dk.

No abstract available

Comment on

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
McInnes IB, Behrens F, Mease PJ, Kavanaugh A, Ritchlin C, Nash P, Masmitja JG, Goupille P, Korotaeva T, Gottlieb AB, Martin R, Ding K, Pellet P, Mpofu S, Pricop L; EXCEED Study Group. McInnes IB, et al. Lancet. 2020 May 9;395(10235):1496-1505. doi: 10.1016/S0140-6736(20)30564-X. Lancet. 2020. PMID: 32386593 Clinical Trial.